{
    "nctId": "NCT06210529",
    "briefTitle": "Clinical Study of High-intensity Focused Ultrasound Tumor Treatment System(Super Knife) in the Treatment of Breast Cancer",
    "officialTitle": "A Single-center, Prospective Clinical Study of High-intensity Focused Ultrasound Tumor Treatment System(Super Knife) in the Treatment of Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 12,
    "primaryOutcomeMeasure": "Pathological complete response (pCR)",
    "eligibilityCriteria": "Inclusion Criteria:\n\nECOG Performance Status of 0-1; Histological confirmed invasive breast cancer; Breast cancer tumor measuring \u22652 cm in maximal diameter and a single lesion as measured by mammogram, breast ultrasound, or breast MRI; Breast tumor's borders from the skin are greater than 1 cm; No lymph node or distant metastasis; Absolute neutrophil count (ANC) \u2265 1.5 \u00d7 109/L, Platelets \u2265 50 \u00d7 109/L, Hemoglobin \u2265 9.0 g/dl iv; Serum creatinine \u22641.5 x upper limit of normal (ULN); AST \u2264 2.5 x ULN, ALT \u2264 2.5 x ULN; Left ventricular ejection fraction \u2265 50%.\n\nExclusion Criteria:\n\nInflammatory breast cancer, bilateral breast cancer, or occult breast cancer; Any kind of prior treatment for breast cancer, including chemotherapy, radiotherapy, endocrine therapy and so on; Pregnant and lactating women; Patients who have participated in other clinical trials.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}